Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postmarketing study of ART-123 in DIC caused by solid tumors
jRCT1080220847Phase 4
- Sponsor
- Asahi Kasei Corporation
- Start
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of thrombomodulin alfa in disseminated intravascular coagulation (DIC) and Nonhematologic neoplasms, sponsored by Asahi Kasei Corporation.
02
Drugs
thrombomodulin alfa
03
Conditions
disseminated intravascular coagulation (DIC)Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT1080220847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220847.